Abstract
High-molecular-weight polysaccharide from Pseudomonas aeruginosa immunotypes 1 and 2 gave cross-protection in outbred CD-1 mice challenged with the heterologous immunotype organism. Both active immunization with 50 micrograms of polysaccharide, as well as passive transfer of immune serum were effective. The basis for this cross-protection is the ability of high doses of polysaccharide to induce antibody formation to both homologous and heterologous immunotype determinants.
Full text
PDF![1117](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d0f/347865/6482baf44f2e/iai00147-0321.png)
![1118](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d0f/347865/ec6aae590696/iai00147-0322.png)
![1119](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d0f/347865/6a6ad5951aac/iai00147-0323.png)
![1120](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d0f/347865/44bb12083333/iai00147-0324.png)
![1121](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d0f/347865/3402d1bff968/iai00147-0325.png)
![1122](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d0f/347865/64eae7c7c442/iai00147-0326.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bergan T. Epidemiological markers for Pseudomonas aeruginosa. 1. Serogrouping, pyocine typing--and their interrelations. Acta Pathol Microbiol Scand B Microbiol Immunol. 1973 Feb;81(1):70–80. [PubMed] [Google Scholar]
- Chester I. R., Meadow P. M., Pitt T. L. The relationship between the O-antigenic lipopolysaccharides and serological specificity in strains of Pseudomonas aeruginosa of different O-serotypes. J Gen Microbiol. 1973 Oct;78(2):305–318. doi: 10.1099/00221287-78-2-305. [DOI] [PubMed] [Google Scholar]
- Fisher M. W., Devlin H. B., Gnabasik F. J. New immunotype schema for Pseudomonas aeruginosa based on protective antigens. J Bacteriol. 1969 May;98(2):835–836. doi: 10.1128/jb.98.2.835-836.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Griffiss J. M., Brandt B. L., Altieri P. L., Pier G. B., Berman S. L. Safety and immunogenicity of group Y and group W135 meningococcal capsular polysaccharide vaccines in adults. Infect Immun. 1981 Dec;34(3):725–732. doi: 10.1128/iai.34.3.725-732.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hanessian S., Regan W., Watson D., Haskell T. H. Isolation and characterization of antigenic components of a new heptavalent Pseudomonas vaccine. Nat New Biol. 1971 Feb 17;229(7):209–210. doi: 10.1038/newbio229209a0. [DOI] [PubMed] [Google Scholar]
- Homma J. Y., Ghoda A., Goto S., Jo K., Kato I., Kodama H., Kosakai N., Kono M., Shionoya H., Terada Y. Proposal of an international standard for the infraspecific serologic classification of Pseudomonas aeruginosa. Jpn J Exp Med. 1979 Feb;49(1):89–94. [PubMed] [Google Scholar]
- Pier G. B. Safety and immunogenicity of high molecular weight polysaccharide vaccine from immunotype 1 Pseudomonas aeruginosa. J Clin Invest. 1982 Feb;69(2):303–308. doi: 10.1172/JCI110453. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pier G. B., Sidberry H. F., Sadoff J. C. High-molecular-weight polysaccharide antigen from Pseudomonas aeruginosa immunotype 2. Infect Immun. 1981 Nov;34(2):461–468. doi: 10.1128/iai.34.2.461-468.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pier G. B., Sidberry H. F., Sadoff J. C. Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa. Infect Immun. 1978 Dec;22(3):919–925. doi: 10.1128/iai.22.3.919-925.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pier G. B., Sidberry H. F., Zolyomi S., Sadoff J. C. Isolation and characterization of a high-molecular-weight polysaccharide from the slime of Pseudomonas aeruginosa. Infect Immun. 1978 Dec;22(3):908–918. doi: 10.1128/iai.22.3.908-918.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Young L. S., Yu B. H., Armstrong D. Agar-Gel Precipitating Antibody in Pseudomonas aeruginosa Infections. Infect Immun. 1970 Oct;2(4):495–503. doi: 10.1128/iai.2.4.495-503.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]